251 related articles for article (PubMed ID: 2127683)
1. Identification of regions of HIV-1 p24 reactive with sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides.
Blomberg J; Vincic E; Jönsson C; Medstrand P; Pipkorn R
AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1363-72. PubMed ID: 2127683
[TBL] [Abstract][Full Text] [Related]
2. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
[TBL] [Abstract][Full Text] [Related]
3. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
4. Differences in human immunodeficiency virus type 1 (HIV-1) anti-p24 reactivities in serum of HIV-1-infected and uninfected subjects: analysis of indeterminate western blot reactions.
Povolotsky J; Gold JW; Chein N; Baron P; Armstrong D
J Infect Dis; 1991 Feb; 163(2):247-51. PubMed ID: 1899100
[TBL] [Abstract][Full Text] [Related]
5. Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products.
Pollock BJ; McKenzie AS; Kemp BE; McPhee DA; D'Apice AJ
Clin Exp Immunol; 1989 Dec; 78(3):323-8. PubMed ID: 2482145
[TBL] [Abstract][Full Text] [Related]
6. Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.
Shang F; Huang H; Revesz K; Chen HC; Herz R; Pinter A
J Virol; 1991 Sep; 65(9):4798-804. PubMed ID: 1714518
[TBL] [Abstract][Full Text] [Related]
7. Identification of a potent synthetic HIV1 immunogen compromising gag-P24 tandem T- and B-cell epitopes.
Chong P; Sia C; Sydor M; Klein M
FEBS Lett; 1990 May; 264(2):231-4. PubMed ID: 1694143
[TBL] [Abstract][Full Text] [Related]
8. Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay.
Busch MP; el Amad Z; McHugh TM; Chien D; Polito AJ
Transfusion; 1991 Feb; 31(2):129-37. PubMed ID: 1899951
[TBL] [Abstract][Full Text] [Related]
9. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
[TBL] [Abstract][Full Text] [Related]
10. HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1.
Mills KH; Kitchin PA; Mahon BP; Barnard AL; Adams SE; Kingsman SM; Kingsman AJ
J Immunol; 1990 Mar; 144(5):1677-83. PubMed ID: 1689753
[TBL] [Abstract][Full Text] [Related]
11. Characterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types 1 and 2.
Niedrig M; Hinkula J; Harthus HP; Bröker M; Hopp L; Pauli G; Wahren B
J Virol; 1991 Aug; 65(8):4529-33. PubMed ID: 1712863
[TBL] [Abstract][Full Text] [Related]
12. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
13. Epitope location of 13 anti-gag HIV-1 monoclonal antibodies using oligopeptides and their cross reactivity with HIV-2.
Ferns RB; Partridge JC; Spence RP; Hunt N; Tedder RS
AIDS; 1989 Dec; 3(12):829-34. PubMed ID: 2483619
[TBL] [Abstract][Full Text] [Related]
14. Immune response to a major epitope of p24 during infection with human immunodeficiency virus type 1 and implications for diagnosis and prognosis.
Janvier B; Baillou A; Archinard P; Mounier M; Mandrand B; Goudeau A; Barin F
J Clin Microbiol; 1991 Mar; 29(3):488-92. PubMed ID: 1709947
[TBL] [Abstract][Full Text] [Related]
15. Epitope mapping of the HIV-1 gag region by analysis of gag gene deletion fragments expressed in Escherichia coli defines eight antigenic determinants.
Marcus-Sekura CJ; Woerner AM; Zhang PF; Klutch M
AIDS Res Hum Retroviruses; 1990 Mar; 6(3):317-27. PubMed ID: 1692722
[TBL] [Abstract][Full Text] [Related]
16. Immune responses to six synthetic peptides of capsid protein with sera from HIV-1 infected individuals.
Liu G; Yang L; Wang J; Zhang G; Chen X; Zheng Y
Cell Mol Immunol; 2005 Aug; 2(4):289-93. PubMed ID: 16274627
[TBL] [Abstract][Full Text] [Related]
17. Reactivities of HIV-1 gag-derived peptides with antibodies of HIV-1-infected and uninfected humans.
Haist S; März J; Wolf H; Modrow S
AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1909-17. PubMed ID: 1489579
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1.
Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG
Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683
[TBL] [Abstract][Full Text] [Related]
19. Yeast-expressed p55 precursor core protein of human immunodeficiency virus type 1 does not elicit protective immunity in chimpanzees.
Emini EA; Schleif WA; Quintero JC; Conard PG; Eichberg JW; Vlasuk GP; Lehman ED; Polokoff MA; Schaeffer TF; Schultz LD
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1247-50. PubMed ID: 2127681
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2.
Carpio E; Duarte C; Hinkula J; Broliden PA; Rosén J; Campal A; Gavilondo J; Wahren B; Jondal M
AIDS Res Hum Retroviruses; 1991 Jan; 7(1):97-101. PubMed ID: 1707645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
